Item 4 — Purpose of Transaction
Initially, the Reporting Persons acquired the shares of Common Stock of the Issuer for investment purposes. The Reporting Persons have reviewed their investment in the Issuer on a continuing basis. The Reporting Persons may in the future, from time to time, dispose of some or all of the securities of the Issuer beneficially owned by them and/or acquire additional securities of the Issuer, in the open market or otherwise, or take any other actions with respect to their investment in the Issuer permitted by law, including any or all of the actions set forth in clauses (a) through (j) of the instructions to Item 4 of Schedule 13D. On 01/09/2025, Ms. Scheffer delivered a letter to the Issuer (the Nomination Letter) nominating a slate of highly qualified director candidates: Ms. Marlow, Mr. Snyder, Mr. Dolpp, and Mr. Alfiero (collectively, the Nominees) for election to the board of directors at the Issuers 2025 annual meeting of stockholders (the Annual Meeting). The Reporting Persons may have conversations with Issuers management and members of the board of directors, and other stockholders, to discuss the Nomination Letter, representation on the board of directors, the Reporting Persons ideas as to how the Issuer may be able to maximize product sales and development and more generally to enhance shareholder value. Except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein, none of the Reporting Persons has any present plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of the instructions to Item 4 of Schedule 13D.